Background:Identifying and addressing the requirements of cancer survivors is currently a high priority for the NHS, yet little is known about the population of cancer survivors in the United Kingdom.Methods:Data from cancer registries in England, Northern Ireland, Scotland and Wales were analysed to provide limited-duration prevalence estimates for 2004. Log-linear regression models were used to extend these to complete prevalence estimates. Trends in prevalence from 2000 to 2004 were used to project complete prevalence estimates forward from 2004 to 2008.Results:We estimated that in total, there were 2 million cancer survivors in the United Kingdom at the end of 2008, ∼3% of the population overall and 1 in 8 of those aged 65 years and more. Prostate and female breast cancers were the most prevalent. The number of cancer survivors is increasing by ∼3% each year. Estimates are also provided by time since diagnosis.Conclusion:These estimates are the most up-to-date available, and as such will be useful for statutory and voluntary sector organisations that are responsible for planning and providing treatment and support to cancer survivors in the United Kingdom.

Background:To compare self-reported health and well-being in a sample of cancer survivors with individuals who have not had cancer and with individuals who have a serious chronic condition other than cancer.Patients and methodsA cross-sectional survey drawn from an online panel of 400 000 UK citizens supplemented with other online recruitment and telephone recruitment. The participants were 4892 individuals 30 years of age or above, including 780 individuals with a previous cancer diagnosis, 1372 individuals with one or more of 10 chronic conditions but not cancer and 2740 individuals without a previous cancer diagnosis or chronic condition. Thirteen measures of health and well-being were constructed from answers to 25 survey items covering physical, psychological and social dimensions of health and well-being.Results:Cancer survivors were significantly more likely to report poor health outcomes across all 13 measures than those with no history of cancer or a chronic condition. The adjusted odds ratios for cancer survivors with no chronic conditions compared with healthy participants ranged from 1.37 (95% confidence interval (CI): 1.31–1.96) for emotional well-being to 3.34 (95% CI: 2.74–4.08) for number of health professionals consulted in the last 12 months. The health profile of cancer survivors was similar to those with a history of a serious chronic health condition.Conclusions:A substantial number of individuals who have had a diagnosis of cancer experience ongoing poor health and well-being following cancer and cancer treatment. The results of this study provide an initial basis for the development of specific help and support for cancer survivors.

Background-Epidemiological studies demonstrate an inverse relation between dietary flavonoid intake and cardiovascular risk. Recent studies with flavonoid-containing beverages suggest that the benefits of these nutrients may relate, in part, to improved endothelial function.

First paragraph: There are approximately 2 million people now living with or beyond cancer in the UK (Maddams et al, 2009) and this number is increasing. Cancer survivors can experience physical, psychological and social consequences as a result of the disease and the treatments received (Jefford et al, 2008; Foster et al, 2009). The effects may be immediate, some of which will resolve and others may persist and become long-term. Late effects can also occur and the interval between the end of treatment and onset can range from a few weeks (e.g. lymphoedema after axillary node removal) to several years (e.g. heart disease following radiotherapy to the chest area). Problems will be individual to each patient due to a unique combination of circumstances including the site and stage of the cancer, the type of treatment(s) given, the age of the patient, genetic factors, concomitant co-morbidities, family and social circumstances, and personality traits

PURPOSE.A large body of research has linked macular lutein and zeaxanthin to reduced risk of degenerative eye disease. The earliest published hypothesis for the role of the pigments was not based on chronic protection but immediate function. Recent data on macular pigment (MP) have shown that screening the foveal cones from short-wave light does, in fact, result in improvements in photostress recovery (PR), glare disability (GD), and chromatic contrast (CC). This study examined those relations on a larger sample. METHODS.A total of 150 young healthy subjects were assessed. Plasma samples were obtained from 100 subjects for HPLC quantification of serum xanthophylls. MP density was measured using customized heterochromatic flicker photometery. GD, PR, and CC were measured in Maxwellian view using a broadband xenon light source. GD was measured by increasing the intensity of an annulus until it veiled a central target. PR was measured as the time necessary to regain sight of a central target after a 5-second exposure to an intense bleaching light. CC was measured as the amount of light necessary in a 460-nm background to lose sight of a central target.RESULTS. MP density was significantly related to serum lutein and zeaxanthin combined (r ¼ 0.31, P ¼ 0.002), GD (r ¼ 0.24, P ¼ 0.0015), PR (r ¼ À0.18, P ¼ 0.01), and CC (r ¼ 0.46, P ¼ 0.00005).CONCLUSIONS. These results confirm earlier reports of a significant relation between variation in macular pigment optical density and immediate effects on visual function. As with many species, intraocular yellow filters in humans appear to improve many aspects of the visual stimulus. (ClinicalTrials. gov number, NCT00909090.) (Invest Ophthalmol Vis Sci.

The influence of connective tissue content on amino acid composition and rat PER was studied in an attempt to develop a regression equation for predicting PERs of meat from the simple chemical analysis of collagen. Collagen content was highly correlated to essential amino acid content and rat PER with correlation coefficients of -0.99 and -0.98, respectively. The developed regression equation, PER = -0.02290 (collagen content) + 3.1528, effectively predicted rat PER within * 0.2 units when tested on various meat ingredients. These results indicated

No abstract

Dietary, clinical, and biochemical data from the Ten-State Nutrition Survey (1968 to 1970) and the Health and Nutrition Examination Survey I (1971 to 1974), have been reexamined by factor analysis to focus attention on eating patterns as a means of relating food intake to health. The seven statistically different eating patterns generated were characterized by disproportionate consumption of different food groups. The relationship between the combination of foods that people ate and the state of their nutritional health was examined for both samples in total, and for various age, sex, race, region, and income groups within the Health and Nutrition Examination Survey I sample. Significantly different associations between the seven eating patterns and the absence of clinical symptoms and biochemical deficiencies were found. Some eating patterns consistently stood out as being significantly better or worse in this regard (p less than 0.05). This food eating pattern model should prove useful for 1) examining the association between food consumption and the incidence of disease states, such as obesity, hypertension, cardiovascular disease, cancer, and periodontal disease for various large scale dietary-health surveys, 2) establishing food regulatory policies, 3) setting national dietary goals, and 4) educating the public on nutrition and health issues.